Table 7.
Reference: normal/mild NAFLD | Male | Female no menopause | Female menopause no hormone | |||
---|---|---|---|---|---|---|
Race/ethnicity | Moderate | Severe | Moderate | Severe | Moderate | Severe |
Non-Hispanic White | Ref | Ref | Ref | Ref | Ref | Ref |
Mexican American | 4.5 [1.7–11.7] | 5.0 [2.1–12.0] | 0.8 [0.2–3.0] | 2.3 [0.6–8.2] | 2.7 [0.2–50.0] | 2.5 [0.2–34.4] |
Other Hispanic | 1.2 [0.5–2.6] | 0.7 [0.3–2.2] | 0.6 [0.1–2.3] | 1.8 [0.7–4.8] | 0.2 [0.0–4.7] | 0.4 [0.0–12.2] |
Non-Hispanic Black | 1.0 [0.5–1.9] | 0.5 [0.3–0.9] | 0.7 [0.4–1.2] | 0.5 [0.3–0.9] | 0.7 [0.2–1.9] | 0.6 [0.2–1.7] |
Other race | 2.3 [0.9–6.0] | 1.3 [0.7–2.6] | 1.0 [0.5–2.3] | 0.8 [0.3–2.5] | 3.6 [1.0–13.2] | 2.0 [0.5–7.8] |
Adjusted for demographic variables (age, race/ethnicity, education, language spoken, and poverty [FIR]), physical activity status, smoking status, diet quality (healthy eating index), body composition (waist-to-hip ratio and body mass index), and laboratory values [cholesterol, HDL, triglyceride, glucose, hemoglobin A1c (HbA1c), highly-sensitive C-reactive protein (hsCRP), AST, and ALT].
Bold = statistically significant at p < 0.05.